Asia Pacific

規制レビュー:AmazonのcGMP要件、NMN、非新規プロバイオティクス菌株

規制レビュー:AmazonのcGMP要件、NMN、非新規プロバイオティクス菌株

By Hui Ling Dang

Amazonが全健康補助食品にcGMP要件を適用、オーストラリア保健省薬品・医薬品行政局がNMNのサプリメント使用を承認、欧州委員会が非新規プロバイオティクス菌株の適用範囲を拡大—これらは、2026年最初の栄養補助食品規制動向まとめにおける最新動向の 一部です。

Japan focus: FFC findings, Kirin’s R&D efforts and more

Japan focus: FFC findings, Kirin’s R&D efforts and more

By Hui Ling Dang

Catch up on recent developments in Japan’s nutraceutical firms and market, including findings from a report on Foods with Function Claims (FFCs), Kirin’s R&D focus and appointment of Shohei Ohtani as “Immune Care” promotion ambassador, and more.

New product round-up: Innovations in supplement delivery

New product round-up: Innovations in supplement delivery

By Asia Sherman

As industry and consumers trend towards supplements that prioritize convenience, sensory experience and improved bioavailability, product launches are increasingly leveraging advanced technologies (and even quantum physics) to deliver innovative formats.

Supplement delivery formats: What’s driving consumer choice?

Supplement delivery formats: What’s driving consumer choice?

By Lauren Nicolle

In a saturated supplement market, brands are increasingly diversifying their product portfolios, offering a range of innovative delivery formats, from popping crystals to sublingual pouches. But which formats are leading the charge, and which are falling...

监管审查:亚马逊 cGMP 规范、NMN、非新资源益生菌菌株

监管审查:亚马逊 cGMP 规范、NMN、非新资源益生菌菌株

By Hui Ling Dang

2026 年首期营养保健食品法规动态的最新进展包括:亚马逊针对所有膳食补充剂产品实施 cGMP 规范要求、澳大利亚药品管理局批准 NMN 用于膳食补充剂,以及欧盟委员会扩大非新资源益生菌菌株的使用范围。

Brand new: Kirin, Nestle, Yili and more in the spotlight

Brand new: Kirin, Nestle, Yili and more in the spotlight

By Tingmin Koe

See new developments from health and nutrition brands across Asia-Pacific, including Kirin’s R&D plans for tackling cellular senescence, Nestle expanding its maternal health supplement range, Yili growing its healthy aging range and more.